RE:No SP reaction to TH1902 good newsBecause it's the middle of the summer, because Thera is an old company with the reputation to be a strong underachiever, because Thera is coming out of nowhere in oncology with a technology developed at Universite du Quebec a Montreal (UQAM), not Harvard, finally, because on partial response will not spark real interest. It is not enough to be sure of anything, in fact, it is far from enough. Personnally I think it is proff of concept, that with the other signs of efficacy, but for a potential new investors not aware of all the details of this story, one partial response in phase Ia is lost in the noise.
TH1902 wrote: Anyone want to speculate why?
I want to believe that we are under the radar and the story needs to be told but the non-response is somewhat disturbing to me.